BACKGROUND: JM-1232(Ϫ) is a novel isoindoline derivative which shows sedative and hypnotic activities through the benzodiazepine site of ␥-aminobutyric acid type A (GABA A ) receptors. Typical doses of midazolam, another GABA A receptor agonist, slightly reduce the shivering threshold in humans. We thus determined the extent to which JM-1232(Ϫ) decreases the shivering threshold. METHODS: Eighteen rabbits, lightly anesthetized with isoflurane 0.2 minimum alveolar anesthetic concentration (MAC), were randomly assigned to infusions of 1) saline (control), 2) 0.01 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 JM-1232(Ϫ), or 3) 0.1 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 JM-1232(Ϫ). Body temperature was reduced at a rate of 2-3°C/h by perfusing water at 10°C though a U-shaped plastic tube positioned in the colon. Cooling continued until shivering was observed by an investigator blinded to treatment, or until core temperature reached 34°C. Core temperatures were recorded from the distal esophagus, and core temperature at the onset of shivering defined the threshold. Data were analyzed by one-way analysis of variance with Student-Newman-Keuls tests. Results are presented as means Ϯ sd; P Ͻ 0.05 was considered statistically significant. RESULTS: The rabbits given a saline infusion shivered at 36.5 Ϯ 0.3°C. Five of the six rabbits given JM-1232(Ϫ) at a rate of 0.01 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 shivered at 35.7 Ϯ 0.8°C, and one of these rabbits failed to shiver at 34.0°C. None of the rabbits given JM-1232(Ϫ) at a rate of 0.1 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 shivered before reaching the 34.0°C cutoff temperature. CONCLUSION: A low dose of JM-1232(Ϫ) reduced the shivering threshold in rabbits approximately 0.8°C which is similar to the effects in humans given premedication doses of midazolam. In contrast, a 10-fold larger dose reduced the threshold more than 2.5°C. This is a substantial decrement and might facilitate induction of therapeutic hypothermia. Peri operative hypothermia is common and causes numerous serious complications. [1] [2] [3] Hypothermia results from the combination of drug-induced impairment of thermoregulatory control 4 and exposure to a cool environment. In practice, however, thermoregulatory impairment and subsequent redistribution of body heat from core to peripheral tissues is the primary cause. 5 General anesthetics profoundly impair thermoregulatory defenses, but thermoregulatory defenses are also impaired by sedatives, including opioids, 6 central ␣ agonists 7, 8 , and nefopam. 9 Typical doses of midazolam, a ␥-aminobutyric acid type A (GABA A ) receptor agonist, slightly reduce the shivering threshold in humans. For example, midazolam at a steady-state plasma concentration of 0.3 L/mL reduced the shivering threshold only 0.6°C in volunteers. 10 This concentration corresponds to an extremely high dose, about 40 mg over the course of 4 h, or about 20 times a typical premedication dose. A subsequent study demonstrated that premedication doses of midazolam slightly reduce core temperature in volunteers.
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JM-1232(Ϫ) is a novel isoindoline derivative which shows sedative and hypnotic activities through the benzodiazepine site of GABA A receptors (GABA A -R), although it acts at a site distinct from midazolam. The drug is water soluble and seems to possess a wide therapeutic index. 12 It also has a shorter elimination half-life than midazolam. We thus tested the hypothesis that JM-1232(Ϫ) has a dose-dependent effect on the shivering thresholds in rabbits.
Yamanashi, we studied 18 male Japanese white rabbits, weighing 2.9 -3.8 (mean, 3.4) kg. The daytime core temperature in these rabbits is usually approximately 39°C. Ambient temperature was maintained near 24°C throughout the study. To exclude the effects of circadian variation on body temperature, studies started about 10:00 and typically concluded near 15:00.
Protocol
Animal preparation was performed as previously described. [13] [14] [15] [16] [17] [18] Briefly, the animals were anesthetized by inhalation of 3%-5% isoflurane and 67% nitrous oxide in oxygen. Each rabbit was intubated with a 3-mm endotracheal tube after local anesthesia by 8% lidocaine spray and subsequently allowed to breathe spontaneously. Nitrous oxide was discontinued and the end-tidal concentration of isoflurane adjusted to 0.2 minimum alveolar anesthetic concentration in 100% oxygen (NORMAC AA-102; GE Health care, Andover, MA).
A catheter was inserted in the marginal ear vein and 3-4 mL ⅐ kg Ϫ1 ⅐ h Ϫ1 lactated Ringer's solution was infused throughout the study. A catheter was inserted into a femoral artery. The animals were loosely restrained in an experimental chamber during the study.
Between 15 and 30 min after the drug or saline infusion was started, core temperature was cooled at a rate of 2 to 3°C/h by perfusing water at 10°C through a U-shaped plastic tube (thermode) positioned in the colon. The animals were randomly assigned to 1 of 3 infusion regimens: 1) saline (control); 2) 0.01
JM-1232(Ϫ). The study ended when shivering was detected or core temperature reached 34°C. At the end of the experiment, each animal was killed by KCl infusion. The concentration of JM-1232(Ϫ) was based on a preliminary study during which we observed that an infusion of 0.1 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 JM-1232(Ϫ) produced an approximately 20 point decrease in Bispectral Index (BIS) (from a lightly anesthetized control baseline value) and eliminated shivering even at a temperature of 34°C. We thus used 0.1 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 JM-1232(Ϫ) as our higher dose, and one-tenth that amount as our lower dose.
Measurements
Core temperatures were recorded from the distal esophagus (MGA 3-219; Nihon Kohden, Tokyo, Japan). Shivering was evaluated via inspection by an observer blinded to the treatment. Arterial blood was sampled for gas analysis (ABL 700TM; Radiometer, Tokyo, Japan) at the time of shivering or at the temperature of 34°C in each rabbit.
Before induction of anesthesia, the animals' heads were shaved. The purpose-built electroencephalogram (EEG) electrodes (BIS sensor XP small size; Aspect Medical Systems, Norwood, MA) were positioned according to the method of Martín-Cancho et al. 19 The electrodes were connected to a BIS monitor (A-2000; Aspect Medical Systems, Norwood, MA).
Data Analysis
A power analysis indicated that 6 rabbits per group were sufficient to detect a 0.8°C difference in esophageal temperature among groups with an ␣ ϭ 0.05 and a power of 0.8 based on a sd of 0.4°C. We performed a 2 test to compare our data with theoretical values and found that our data were normally distributed.
The core temperature triggering sustained vigorous shivering defined the shivering threshold. Results were analyzed with one-way analysis of variance and Student-Newman-Keuls tests. Data are expressed as means Ϯ sd; P Ͻ 0.05 was considered statistically significant.
RESULTS
Responses in each group at the time of shivering or at the temperature of 34°C are shown in Table 1 . Except for mean arterial blood pressure, heart rate and Paco 2 , hemodynamic and respiratory responses at the time of shivering or at a temperature of 34°C were not significantly different.
All six rabbits given a saline infusion shivered at an average of 36.5 Ϯ 0.3°C. In contrast, 5 of the 6 rabbits given 0.01 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 of JM-1232(Ϫ) shivered at 35.7 Ϯ 0.8°C; one rabbit in this group failed to shiver at a minimum core temperature of 34.0°C. In contrast, none of the rabbits shivered at a minimum core temperature of 34.0°C with the larger 0.1 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 dose of JM-1232(Ϫ). The shivering thresholds were significantly different among the groups (Fig. 1) .
Steady-state (lightly anesthetized) BIS values before core cooling are shown in Figure 2 . BIS in the control groups was 75 Ϯ 6. Both doses of JM-1232(Ϫ) significantly reduced the BIS to approximately 50; however, there were no statistically significant nor clinically important differences in BIS between the two treatment groups, even though the doses differed by an order of magnitude. We quantified the shivering threshold. However, shivering is only one important cold defense in humans; the other is arteriovenous shunt vasoconstriction. Shunt vasoconstriction is an effective defense that constrains metabolic heat to the thermal core, thus preserving core temperature. With the exception of meperidine 20 and nefopam, 9 the vasoconstriction and shivering thresholds are reduced in parallel by drugs that impair central thermoregulatory control. Typically, the vasoconstriction is about 1°C more than the shivering threshold, 21 a relationship that is maintained at any given dose of various drugs. 4, 22 It is thus most likely that the reduction in vasoconstriction induced by JM-1232(Ϫ) parallels that observed for shivering, although this theory remains to be confirmed.
Thermoregulatory defenses are generally salutary in that they help maintain core temperature homeostasis. However, mild hypothermia (i.e., 2-3°C reductions in tissue temperature) provides considerable protection against ischemia in numerous animal models. 23, 24 Hypothermia has also been proven beneficial during recovery from cardiac arrest 25, 26 and in asphyxiated neonates. 27, 28 It is easy to induce and maintain hypothermia in these populations, but it can be challenging in the context of acute myocardial infarction or stroke, which are potential (although yet to be proven) targets of therapeutic hypothermia. Some drugs or drug combinations have been shown to induce a degree of thermal tolerance, 29, 30 but typically at the risk of some complications. Investigators are thus actively looking for other, less toxic ways to blunt thermoregulatory defenses. The higher dose of JM-1232(Ϫ) obliterated shivering, at least to our cutoff temperature of 34°C. It remains to be determined whether such high doses will be tolerated in humans without respiratory or other complications. But to the extent that high doses can be used safely, JM-1232(Ϫ) might facilitate induction of therapeutic hypothermia.
Few studies have been reported evaluating the use of BIS assessments in veterinary practice, despite its extensive validation and use in humans. 31 However, rabbits have been used to study the EEG effects of anesthetics, and EEG has been used to evaluate the depth of anesthesia when using injectable combinations in this species. Although the BIS algorithm of humans may not be applicable to that of rabbits, BIS values may at least roughly help determine anesthetic depth in rabbits. 19, 32 Furthermore, BIS values correlate with the Observers' Assessment of Alertness/Sedation score in patients given midazolam for sedation. 33 Nonetheless, hypnotic depth in our rabbits, as evaluated with BIS monitoring, should thus be considered only a rough estimate of anesthetic effect.
Before core cooling, BIS values were approximately 75 in the rabbis given saline and 0.2 minimum alveolar concentration isoflurane. BIS significantly decreased approximately 25 points with each drug dose, but, despite 10 times the concentration of the drug, BIS levels between the 0.01 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 and 0.1 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 drug-infusion groups did not differ significantly. This apparent ceiling effect with respect to sedation differs markedly from the drug's thermoregulatory effect, which showed a distinct dose response. Therefore, the reduction in the shivering threshold seems to be independent from the depth of sedation.
JM-1232(Ϫ) remains in preclinical evaluation and is therefore unavailable for use in volunteers or patients. A consequent limitation of our study is that it was conducted in rabbits rather than humans. What the analogous doses in humans might be remain unknown. It is thus possible that the doses we tested, although spanning a 10-fold range, may not cover the range subsequently determined to be therapeutic in humans.
In summary, a low dose of JM-1232(Ϫ) reduced the shivering threshold approximately 0.8°C, which is similar to the effects in humans given premedication doses of midazolam. In contrast, a dose 10-fold larger reduced the threshold more than 2.5°C. This is a substantial decrement and might facilitate induction of therapeutic hypothermia.
